Baxter
BAX
£21.35
Share price
-2.40%
Change (1 day)
-23.76%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
P/S ratio for Baxter (BAX)
P/S ratio as of July 2025 (TTM): 1.23
According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.07. At the end of 2025 the company had a P/S ratio of 1.46.
P/S ratio history for Baxter from 2001 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 1.46 | 14.79% |
| 2024 | 1.27 | -11.37% |
| 2023 | 1.43 | -17.58% |
| 2022 | 1.74 | -48.35% |
| 2021 | 3.36 | -4.25% |
| 2020 | 3.51 | -5.74% |
| 2019 | 3.73 | 22.69% |
| 2018 | 3.04 | -8.95% |
| 2017 | 3.33 | 40.52% |
| 2016 | 2.37 | 13.22% |
| 2015 | 2.10 | -19.94% |
| 2014 | 2.62 | 5.33% |
| 2013 | 2.49 | -3.13% |
| 2012 | 2.57 | 27.77% |
| 2011 | 2.01 | -12.26% |
| 2010 | 2.29 | -18.46% |
| 2009 | 2.81 | 4.3% |
| 2008 | 2.69 | -17.69% |
| 2007 | 3.27 | 12.46% |
| 2006 | 2.91 | 21.72% |
| 2005 | 2.39 | 6.43% |
| 2004 | 2.24 | 6.73% |
| 2003 | 2.10 | 0.67% |
| 2002 | 2.09 | -50.16% |
| 2001 | 4.19 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Cardinal Health CAH | 0.1680 | -86.35% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.60 | 435.75% | 🇺🇸 USA |
 Boston Scientific BSX | 8.92 | 624.65% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.51 | 104.11% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 6.56 | 432.92% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 4.27 | 246.66% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |
 Owens & Minor
OMI | 0.0562 | -95.43% | 🇺🇸 USA |
 Medtronic MDT | 3.51 | 185.42% | 🇮🇪 Ireland |
 ICU Medical
ICUI | 1.30 | 5.33% | 🇺🇸 USA |